In silico profiling of Escherichia coli and Saccharomyces cerevisiae as terpenoid factories

Microbial Cell Factories

Volumn 12, Issue 1, 2013, Pages

  Gruchattka, Evamaria ^a   Hädicke, Oliver ^b   Klamt, Steffen ^b   Schütz, Verena ^a,c   Kayser, Oliver ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^c Biomax Informatics AG   (Germany)

Author keywords

Constrained minimal cut sets; Elementary mode analysis; Escherichia coli; In silico; Isoprenoids; Metabolic engineering; Saccharomyces cerevisiae; Terpenoids

Indexed keywords

ACETYL COENZYME A; CARBON; TERPENOID;

ARTICLE; CARBON METABOLISM; CARBON SOURCE; COMPUTER MODEL; ENERGY; ESCHERICHIA COLI; METABOLIC ENGINEERING; NONHUMAN; SACCHAROMYCES CEREVISIAE; STOICHIOMETRY;

ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

COMPUTER SIMULATION; ESCHERICHIA COLI; METABOLIC ENGINEERING; SACCHAROMYCES CEREVISIAE; TERPENES;

EID: 84884376873     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-12-84     Document Type: Article

References (86)

1. Hong KK, Nielsen J. Metabolic engineering of Saccharomyces cerevisiae: a key cell factory platform for future biorefineries. Cell Mol Life Sci 2012, 69:2671-2690. 10.1007/s00018-012-0945-1, 22388689.
2. Kirby J, Keasling JD. Biosynthesis of plant isoprenoids: perspectives for microbial engineering. Annu Rev Plant Biol 2009, 60:335-355. 10.1146/annurev.arplant.043008.091955, 19575586.
3. Woodrow CJ, Haynes RK, Krishna S. Artemisinins. Postgrad Med J 2005, 81:71-78. 10.1136/pgmj.2004.028399, 1743191, 15701735.
4. Davies HM. Organic chemistry: Synthetic lessons from nature. Nature 2009, 459:786-787. 10.1038/459786a, 19516330.
5. Jiang M, Stephanopoulos G, Pfeifer BA. Toward biosynthetic design and implementation of Escherichia coli-derived paclitaxel and other heterologous polyisoprene compounds. Appl Environ Microbiol 2012, 78:2497-2504. 10.1128/AEM.07391-11, 3318847, 22287010.
6. Kirby J, Keasling JD. Metabolic engineering of microorganisms for isoprenoid production. Nat Prod Rep 2008, 25:656-661. 10.1039/b802939c, 18663389.
7. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943. 10.1038/nature04640, 16612385.
8. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A 2012, 109:E111-E118. 10.1073/pnas.1110740109, 3271868, 22247290.
9. Chang MC, Eachus RA, Trieu W, Ro DK, Keasling JD. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 2007, 3:274-277. 10.1038/nchembio875, 17438551.
10. Farhi M, Marhevka E, Masci T, Marcos E, Eyal Y, Ovadis M, Abeliovich H, Vainstein A. Harnessing yeast subcellular compartments for the production of plant terpenoids. Metab Eng 2011, 13:474-481. 10.1016/j.ymben.2011.05.001, 21601648.
11. Kampranis SC, Makris AM. Developing a yeast cell factory for the production of terpenoids. Comput Struct Biotechnol J 2012, 3:1-7.
12. Maury J, Asadollahi MA, Moller K, Clark A, Nielsen J. Microbial isoprenoid production: an example of green chemistry through metabolic engineering. Adv Biochem Eng Biotechnol 2005, 100:19-51.
13. Partow S, Siewers V, Daviet L, Schalk M, Nielsen J. Reconstruction and evaluation of the synthetic bacterial MEP Pathway in Saccharomyces cerevisiae. PLoS One 2012, 7:e52498. 10.1371/journal.pone.0052498, 3532213, 23285068.
14. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74. 10.1126/science.1191652, 3034138, 20929806.
15. Huang Q, Roessner CA, Croteau R, Scott AI. Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol. Bioorg Med Chem 2001, 9:2237-2242. 10.1016/S0968-0896(01)00072-4, 11553461.
16. Kim SW, Keasling JD. Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. Biotechnol Bioeng 2001, 72:408-415. 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H, 11180061.
17. Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 2003, 21:796-802. 10.1038/nbt833, 12778056.
18. Morrone D, Lowry L, Determan MK, Hershey DM, Xu M, Peters RJ. Increasing diterpene yield with a modular metabolic engineering system in E. coli: comparison of MEV and MEP isoprenoid precursor pathway engineering. Appl Microbiol Biotechnol 2010, 85:1893-1906. 10.1007/s00253-009-2219-x, 2811251, 19777230.
19. Rodriguez-Villalon A, Perez-Gil J, Rodriguez-Concepcion M. Carotenoid accumulation in bacteria with enhanced supply of isoprenoid precursors by upregulation of exogenous or endogenous pathways. J Biotechnol 2008, 135:78-84. 10.1016/j.jbiotec.2008.02.023, 18417238.
20. Yuan LZ, Rouviere PE, Larossa RA, Suh W. Chromosomal promoter replacement of the isoprenoid pathway for enhancing carotenoid production in E. coli. Metab Eng 2006, 8:79-90. 10.1016/j.ymben.2005.08.005, 16257556.
21. Zhou K, Zhou L, Lim Q, Zou R, Stephanopoulos G, Too HP. Novel reference genes for quantifying transcriptional responses of Escherichia coli to protein overexpression by quantitative PCR. BMC Mol Biol 2011, 12:18. 10.1186/1471-2199-12-18, 3110127, 21513543.
22. Kizer L, Pitera DJ, Pfleger BF, Keasling JD. Application of functional genomics to pathway optimization for increased isoprenoid production. Appl Environ Microbiol 2008, 74:3229-3241. 10.1128/AEM.02750-07, 2394933, 18344344.
23. Pitera DJ, Paddon CJ, Newman JD, Keasling JD. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng 2007, 9:193-207. 10.1016/j.ymben.2006.11.002, 17239639.
24. Tsuruta H, Paddon CJ, Eng D, Lenihan JR, Horning T, Anthony LC, Regentin R, Keasling JD, Renninger NS, Newman JD. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS One 2009, 4:e4489. 10.1371/journal.pone.0004489, 2637983, 19221601.
25. Yoon SH, Lee SH, Das A, Ryu HK, Jang HJ, Kim JY, Oh DK, Keasling JD, Kim SW. Combinatorial expression of bacterial whole mevalonate pathway for the production of beta-carotene in E. coli. J Biotechnol 2009, 140:218-226. 10.1016/j.jbiotec.2009.01.008, 19428716.
26. Polakowski T, Stahl U, Lang C. Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast. Appl Microbiol Biotechnol 1998, 49:66-71. 10.1007/s002530051138, 9487712.
27. Donald KA, Hampton RY, Fritz IB. Effects of overproduction of the catalytic domain of 3-hydroxy-3-methylglutaryl coenzyme a reductase on squalene synthesis in Saccharomyces cerevisiae. Appl Environ Microbiol 1997, 63:3341-3344. 168639, 9292983.
28. Gardner RG, Hampton RY. A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase in eukaryotes. J Biol Chem 1999, 274:31671-31678. 10.1074/jbc.274.44.31671, 10531376.
29. Paradise EM, Kirby J, Chan R, Keasling JD. Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase. Biotechnol Bioeng 2008, 100:371-378. 10.1002/bit.21766, 18175359.
30. Asadollahi MA, Maury J, Moller K, Nielsen KF, Schalk M, Clark A, Nielsen J. Production of plant sesquiterpenes in Saccharomyces cerevisiae: effect of ERG9 repression on sesquiterpene biosynthesis. Biotechnol Bioeng 2008, 99:666-677. 10.1002/bit.21581, 17705244.
31. Scalcinati G, Partow S, Siewers V, Schalk M, Daviet L, Nielsen J. Combined metabolic engineering of precursor and co-factor supply to increase alpha-santalene production by Saccharomyces cerevisiae. Microb Cell Fact 2012, 11:117. 10.1186/1475-2859-11-117, 3527295, 22938570.
32. Melzer G, Esfandabadi ME, Franco-Lara E, Wittmann C. Flux Design: In silico design of cell factories based on correlation of pathway fluxes to desired properties. BMC Syst Biol 2009, 3:120. 10.1186/1752-0509-3-120, 2808316, 20035624.
33. Papin JA, Stelling J, Price ND, Klamt S, Schuster S, Palsson BO. Comparison of network-based pathway analysis methods. Trends Biotechnol 2004, 22:400-405. 10.1016/j.tibtech.2004.06.010, 15283984.
34. Schuster S, Fell DA, Dandekar T. A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks. Nat Biotechnol 2000, 18:326-332. 10.1038/73786, 10700151.
35. Schuster S, Hilgetag C, Woods JH, Fell DA. Reaction routes in biochemical reaction systems: algebraic properties, validated calculation procedure and example from nucleotide metabolism. J Math Biol 2002, 45:153-181. 10.1007/s002850200143, 12181603.
36. Trinh CT, Wlaschin A, Srienc F. Elementary mode analysis: a useful metabolic pathway analysis tool for characterizing cellular metabolism. Appl Microbiol Biotechnol 2009, 81:813-826. 10.1007/s00253-008-1770-1, 2909134, 19015845.
37. Krömer JO, Wittmann C, Schröder H, Heinzle E. Metabolic pathway analysis for rational design of L-methionine production by Escherichia coli and Corynebacterium glutamicum. Metab Eng 2006, 8:353-369. 10.1016/j.ymben.2006.02.001, 16621639.
38. Carlson R, Fell D, Srienc F. Metabolic pathway analysis of a recombinant yeast for rational strain development. Biotechnol Bioeng 2002, 79:121-134. 10.1002/bit.10305, 12115428.
39. Carlson R, Srienc F. Fundamental Escherichia coli biochemical pathways for biomass and energy production: identification of reactions. Biotechnol Bioeng 2004, 85:1-19. 10.1002/bit.10812, 14705007.
40. Hädicke O, Klamt S. Computing complex metabolic intervention strategies using constrained minimal cut sets. Metab Eng 2011, 13:204-213. 10.1016/j.ymben.2010.12.004, 21147248.
41. Unrean P, Trinh CT, Srienc F. Rational design and construction of an efficient E. coli for production of diapolycopendioic acid. Metab Eng 2010, 12:112-122. 10.1016/j.ymben.2009.11.002, 2875070, 19944775.
42. Trinh CT, Carlson R, Wlaschin A, Srienc F. Design, construction and performance of the most efficient biomass producing E. coli bacterium. Metab Eng 2006, 8:628-638. 10.1016/j.ymben.2006.07.006, 16997589.
43. Trinh CT, Unrean P, Srienc F. Minimal Escherichia coli cell for the most efficient production of ethanol from hexoses and pentoses. Appl Environ Microbiol 2008, 74:3634-3643. 10.1128/AEM.02708-07, 2446564, 18424547.
44. Trinh CT, Srienc F. Metabolic engineering of Escherichia coli for efficient conversion of glycerol to ethanol. Appl Environ Microbiol 2009, 75:6696-6705. 10.1128/AEM.00670-09, 2772450, 19734340.
45. Alper H, Miyaoku K, Stephanopoulos G. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat Biotechnol 2005, 23:612-616. 10.1038/nbt1083, 15821729.
46. Asadollahi MA, Maury J, Patil KR, Schalk M, Clark A, Nielsen J. Enhancing sesquiterpene production in Saccharomyces cerevisiae through in silico driven metabolic engineering. Metab Eng 2009, 11:328-334. 10.1016/j.ymben.2009.07.001, 19619667.
47. Choi HS, Lee SY, Kim TY, Woo HM. In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol 2010, 76:3097-3105. 10.1128/AEM.00115-10, 2869140, 20348305.
48. Shiba Y, Paradise EM, Kirby J, Ro DK, Keasling JD. Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids. Metab Eng 2007, 9:160-168. 10.1016/j.ymben.2006.10.005, 17196416.
49. Farmer WR, Liao JC. Precursor balancing for metabolic engineering of lycopene production in Escherichia coli. Biotechnol Prog 2001, 17:57-61. 10.1021/bp000137t, 11170480.
50. Zhao J, Li Q, Sun T, Zhu X, Xu H, Tang J, Zhang X, Ma Y. Engineering central metabolic modules of Escherichia coli for improving β-carotene production. Metab Eng 2013, 17:42-50.
51. Navarro-Avino JP, Prasad R, Miralles VJ, Benito RM, Serrano R. A proposal for nomenclature of aldehyde dehydrogenases in Saccharomyces cerevisiae and characterization of the stress-inducible ALD2 and ALD3 genes. Yeast 1999, 15:829-842. 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9, 10407263.
52. Carlsen S, Ajikumar PK, Formenti LR, Zhou K, Phon TH, Nielsen ML, Lantz AE, Kielland-Brandt MC, Stephanopoulos G. Heterologous expression and characterization of bacterial 2-C-methyl-D-erythritol-4-phosphate pathway in Saccharomyces cerevisiae. Appl Microbiol Biotechnol 2013, 97:5753-5769. 10.1007/s00253-013-4877-y, 23636690.
53. Dobson R, Gray V, Rumbold K. Microbial utilization of crude glycerol for the production of value-added products. J Ind Microbiol Biotechnol 2012, 39:217-226. 10.1007/s10295-011-1038-0, 21948485.
54. Randez-Gil F, Sanz P, Prieto JA. Engineering baker's yeast: room for improvement. Trends Biotechnol 1999, 17:237-244. 10.1016/S0167-7799(99)01318-9, 10354561.
55. Carvalheiro F, Duarte LC, Gírio FM. Hemicellulose biorefineries: a review on biomass pretreatments. J Sci Ind Res 2008, 67:849-864.
56. Pandey A, Soccol CR, Nigam P, Soccol VT. Biotechnological potential of agro-industrial residues: I: sugarcane bagasse. Bioresour Technol 2000, 74:69-80.
57. da Silva GP, Mack M, Contiero J. Glycerol: a promising and abundant carbon source for industrial microbiology. Biotechnol Adv 2009, 27:30-39. 10.1016/j.biotechadv.2008.07.006, 18775486.
58. Karhumaa K, Garcia Sanchez R, Hahn-Hagerdal B, Gorwa-Grauslund MF. Comparison of the xylose reductase-xylitol dehydrogenase and the xylose isomerase pathways for xylose fermentation by recombinant Saccharomyces cerevisiae. Microb Cell Fact 2007, 6:5. 10.1186/1475-2859-6-5, 1797182, 17280608.
59. Meng H, Wang Y, Hua Q, Zhang S, Wang X. In silico analysis and experimental improvement of taxadiene heterologous biosynthesis in Escherichia coli. Biotechnol Bioprocess Eng 2011, 16:205-215.
60. Wang C, Yoon SH, Shah AA, Chung YR, Kim JY, Choi ES, Keasling JD, Kim SW. Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway. Biotechnol Bioeng 2010, 107:421-429. 10.1002/bit.22831, 20552672.
61. Muramatsu M, Ohto C, Obata S, Sakuradani E, Shimizu S. Alkaline pH enhances farnesol production by Saccharomyces cerevisiae. J Biosci Bioeng 2009, 108:52-55. 10.1016/j.jbiosc.2009.02.012, 19577192.
62. Lindahl AL, Olsson ME, Mercke P, Tollbom O, Schelin J, Brodelius M, Brodelius PE. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. Biotechnol Lett 2006, 28:571-580. 10.1007/s10529-006-0015-6, 16614895.
63. Gunawardena U, Meinhold P, Peters MW, Urano RM, Feldmann RMR. Butanol production by metabolically engineered yeast 2010, US 2010/0062505 A1.
64. Hansen J. Method of producing isoprenoid compounds in yeast 2013, US 2013/0137138 A1.
65. Nissen TL, Anderlund M, Nielsen J, Villadsen J, Kielland-Brandt MC. Expression of a cytoplasmic transhydrogenase in Saccharomyces cerevisiae results in formation of 2-oxoglutarate due to depletion of the NADPH pool. Yeast 2001, 18:19-32. 10.1002/1097-0061(200101)18:1<19::AID-YEA650>3.0.CO;2-5, 11124698.
66. Jeun Y-S, Kim M-D, Park Y-C, Lee T-H, Yoo M-S, Ryu Y-W, Seo J-H. Expression of Azotobacter vinelandii soluble transhydrogenase perturbs xylose reductase-mediated conversion of xylose to xylitol by recombinant Saccharomyces cerevisiae. J Mol Cata B: Enzym 2003, 26:251-256.
67. Anderlund M, Nissen TL, Nielsen J, Villadsen J, Rydstrom J, Hahn-Hagerdal B, Kielland-Brandt MC. Expression of the Escherichia coli pntA and pntB genes, encoding nicotinamide nucleotide transhydrogenase, in Saccharomyces cerevisiae and its effect on product formation during anaerobic glucose fermentation. Appl Environ Microbiol 1999, 65:2333-2340. 91345, 10347010.
68. Fong SS, Burgard AP, Herring CD, Knight EM, Blattner FR, Maranas CD, Palsson BO. In silico design and adaptive evolution of Escherichia coli for production of lactic acid. Biotechnol Bioeng 2005, 91:643-648. 10.1002/bit.20542, 15962337.
69. Ibarra RU, Edwards JS, Palsson BO. Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth. Nature 2002, 420:186-189. 10.1038/nature01149, 12432395.
70. Sauer U, Canonaco F, Heri S, Perrenoud A, Fischer E. The soluble and membrane-bound transhydrogenases UdhA and PntAB have divergent functions in NADPH metabolism of Escherichia coli. J Biol Chem 2004, 279:6613-6619.
71. Blank LM, Kuepfer L, Sauer U. Large-scale 13C-flux analysis reveals mechanistic principles of metabolic network robustness to null mutations in yeast. Genome Biol 2005, 6:R49. 10.1186/gb-2005-6-6-r49, 1175969, 15960801.
72. Luttik MA, Overkamp KM, Kotter P, de Vries S, van Dijken JP, Pronk JT. The Saccharomyces cerevisiae NDE1 and NDE2 genes encode separate mitochondrial NADH dehydrogenases catalyzing the oxidation of cytosolic NADH. J Biol Chem 1998, 273:24529-24534. 10.1074/jbc.273.38.24529, 9733747.
73. Boles E, de Jong-Gubbels P, Pronk JT. Identification and characterization of MAE1, the Saccharomyces cerevisiae structural gene encoding mitochondrial malic enzyme. J Bacteriol 1998, 180:2875-2882. 107252, 9603875.
74. Aguilera A. Deletion of the phosphoglucose isomerase structural gene makes growth and sporulation glucose dependent in Saccharomyces cerevisiae. Mol Gen Genet 1986, 204:310-316. 10.1007/BF00425515, 3020369.
75. Klamt S, Gilles ED. Minimal cut sets in biochemical reaction networks. Bioinformatics 2004, 20:226-234. 10.1093/bioinformatics/btg395, 14734314.
76. Klamt S. Generalized concept of minimal cut sets in biochemical networks. Biosystems 2006, 83:233-247. 10.1016/j.biosystems.2005.04.009, 16303240.
77. Klamt S, Saez-Rodriguez J, Gilles ED. Structural and functional analysis of cellular networks with Cell NetAnalyzer. BMC Syst Biol 2007, 1:2. 10.1186/1752-0509-1-2, 1847467, 17408509.
78. Förster J, Gombert AK, Nielsen J. A functional genomics approach using metabolomics and in silico pathway analysis. Biotechnol Bioeng 2002, 79:703-712. 10.1002/bit.10378, 12209793.
79. Nookaew I, Meechai A, Thammarongtham C, Laoteng K, Ruanglek V, Cheevadhanarak S, Nielsen J, Bhumiratana S. Identification of flux regulation coefficients from elementary flux modes: a systems biology tool for analysis of metabolic networks. Biotechnol Bioeng 2007, 97:1535-1549. 10.1002/bit.21339, 17238207.
80. Puustinen A, Finel M, Haltia T, Gennis RB, Wikstrom M. Properties of the two terminal oxidases of Escherichia coli. Biochemistry 1991, 30:3936-3942. 10.1021/bi00230a019, 1850294.
81. Cherry JM, Hong EL, Amundsen C, Balakrishnan R, Binkley G, Chan ET, Christie KR, Costanzo MC, Dwight SS, Engel SR, et al. Saccharomyces genome database: the genomics resource of budding yeast. Nucleic Acids Res 2012, 40:D700-D705. 10.1093/nar/gkr1029, 3245034, 22110037.
82. Herrgard MJ, Swainston N, Dobson P, Dunn WB, Arga KY, Arvas M, Bluthgen N, Borger S, Costenoble R, Heinemann M, et al. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat Biotechnol 2008, 26:1155-1160. 10.1038/nbt1492, 18846089.
83. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40:D109-D114. 10.1093/nar/gkr988, 3245020, 22080510.
84. Keseler IM, Collado-Vides J, Santos-Zavaleta A, Peralta-Gil M, Gama-Castro S, Muniz-Rascado L, Bonavides-Martinez C, Paley S, Krummenacker M, Altman T, et al. EcoCyc: a comprehensive database of Escherichia coli biology. Nucleic Acids Res 2011, 39:D583-D590. 10.1093/nar/gkq1143, 3013716, 21097882.
85. Nookaew I, Jewett MC, Meechai A, Thammarongtham C, Laoteng K, Cheevadhanarak S, Nielsen J, Bhumiratana S. The genome-scale metabolic model iIN800 of Saccharomyces cerevisiae and its validation: a scaffold to query lipid metabolism. BMC Syst Biol 2008, 2:71. 10.1186/1752-0509-2-71, 2542360, 18687109.
86. Schomburg I, Chang A, Placzek S, Sohngen C, Rother M, Lang M, Munaretto C, Ulas S, Stelzer M, Grote A, et al. BRENDA in 2013: integrated reactions, kinetic data, enzyme function data, improved disease classification: new options and contents in BRENDA. Nucleic Acids Res 2013, 41:D764-D772. 10.1093/nar/gks1049, 3531171, 23203881.